LHC Group Inc. (LHCG)
NASDAQ: LHCG
· Real-Time Price · USD
169.81
0.00 (0.00%)
At close: Feb 21, 2023, 10:00 PM
LHC Revenue Breakdown
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare Innovations Revenue | 35.29M | 35.2M | 32.46M | 29.66M | 33.1M | 82.47M | 70.09M | 76.12M | 73.35M | 75.39M | 1M |
| Healthcare Innovations Revenue Growth | +0.24% | +8.46% | +9.42% | -10.39% | -59.86% | +17.67% | -7.93% | +3.78% | -2.71% | +7439.20% | n/a |
| Facility Based Services Revenue | 127.92M | 132.1M | 128.58M | 111.81M | 113.78M | 783.51M | 665.9M | 613.19M | 592.66M | 582.89M | 563.74M |
| Facility Based Services Revenue Growth | -3.17% | +2.74% | +15.00% | -1.74% | -85.48% | +17.66% | +8.60% | +3.46% | +1.68% | +3.40% | n/a |
| Home And Community-Based Services Revenue | 180.59M | 189.56M | 1.46B | 1.5B | 1.29B | 159.2M | 134.95M | 85.85M | 67.62M | n/a | n/a |
| Home And Community-Based Services Revenue Growth | -4.73% | -87.05% | -2.63% | +16.41% | +711.23% | +17.97% | +57.18% | +26.96% | n/a | n/a | n/a |
| Home Based Services Revenue | 1.53B | 1.55B | 243.81M | 226.92M | 199.12M | n/a | n/a | n/a | n/a | n/a | n/a |
| Home Based Services Revenue Growth | -1.29% | +536.38% | +7.44% | +13.96% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Hospice Entity Revenue | 407.49M | 311.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Hospice Entity Revenue Growth | +30.93% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 188.78M | 183.29M | 190.28M | 178.74M | 183.66M | 171.09M | 162.52M | 163.25M | 162.94M | 205.9M | 106.14M | 157.87M | 155.37M | 146.83M | 148.58M | 145.22M | 145.98M | 149.92M | 141.35M | 92.03M | 90.71M | 78.86M | 76.22M | 74.38M | 72.46M | 70.27M | 72.04M | 70.84M | 72.58M | 65.56M | 65.17M | 64.56M |
| Selling, General, and Administrative Revenue Growth | +2.99% | -3.68% | +6.46% | -2.68% | +7.35% | +5.27% | -0.45% | +0.19% | -20.86% | +93.99% | -32.77% | +1.61% | +5.82% | -1.18% | +2.32% | -0.52% | -2.63% | +6.06% | +53.59% | +1.46% | +15.02% | +3.46% | +2.48% | +2.65% | +3.11% | -2.46% | +1.70% | -2.40% | +10.72% | +0.59% | +0.96% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |